<p>Serum total testosterone (A) and DHEAS (B) levels in PCOS patients and controls. C. Prevalence of hirsutism, OA, and PCOM in PCOS patients and controls. D. Prevalence of phenotypes within PCOS patients according to the Rotterdam Criteria. PCOM: polycystic ovarian morphology, OA: oligo-/amenorrhoea, HA: hyperandrogenism (clinical and/or biochemical).</p
Polycystic ovary syndrome (PCOS) was first described by Stein and Leventhal in 1935 (1). The combina...
OBJECTIVE: Application of the newly introduced Rotterdam criteria for polycystic ovary syndrome (PCO...
none12siThe diagnosis of polycystic ovary syndrome (PCOS) remains challenging due to limited data re...
New diagnostic criteria for polycystic ovary syndrome (PCOS) suggested three main phenotypes: classi...
Abstract OBJECTIVE: To evaluate the clinical and endocrine differences between main polycystic ovary...
Polycystic ovary syndrome (PCOS) is a common endocrine disorderand is a major cause of an ovulatory ...
Background: Policystic ovary syndrome (PCOS) is a very common endocrine disease in women of reproduc...
Background: Polycystic Ovary Syndrome (PCOS) represents one of the major causes of infertility in wo...
The aim of this study was to calculate the relative prevalence of all phenotypes of polycystic ovary...
Since the 1990 National Institutes of Health–sponsored conference on polycystic ovary syndrome (PCOS...
ObjectiveTo review all available data and recommend a definition for polycystic ovary syndrome (PCOS...
Polycystic ovarian syndrome (PCOS), includes a wide spectrum of clinical symptoms and signs. Three ...
Copyright © 2006 by The Endocrine SocietyObjective: The Androgen Excess Society (AES) charged a task...
Objective.This study was designed to assess the diagnostic potency of different androgens in hyperan...
Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that affects a large proportion of ...
Polycystic ovary syndrome (PCOS) was first described by Stein and Leventhal in 1935 (1). The combina...
OBJECTIVE: Application of the newly introduced Rotterdam criteria for polycystic ovary syndrome (PCO...
none12siThe diagnosis of polycystic ovary syndrome (PCOS) remains challenging due to limited data re...
New diagnostic criteria for polycystic ovary syndrome (PCOS) suggested three main phenotypes: classi...
Abstract OBJECTIVE: To evaluate the clinical and endocrine differences between main polycystic ovary...
Polycystic ovary syndrome (PCOS) is a common endocrine disorderand is a major cause of an ovulatory ...
Background: Policystic ovary syndrome (PCOS) is a very common endocrine disease in women of reproduc...
Background: Polycystic Ovary Syndrome (PCOS) represents one of the major causes of infertility in wo...
The aim of this study was to calculate the relative prevalence of all phenotypes of polycystic ovary...
Since the 1990 National Institutes of Health–sponsored conference on polycystic ovary syndrome (PCOS...
ObjectiveTo review all available data and recommend a definition for polycystic ovary syndrome (PCOS...
Polycystic ovarian syndrome (PCOS), includes a wide spectrum of clinical symptoms and signs. Three ...
Copyright © 2006 by The Endocrine SocietyObjective: The Androgen Excess Society (AES) charged a task...
Objective.This study was designed to assess the diagnostic potency of different androgens in hyperan...
Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that affects a large proportion of ...
Polycystic ovary syndrome (PCOS) was first described by Stein and Leventhal in 1935 (1). The combina...
OBJECTIVE: Application of the newly introduced Rotterdam criteria for polycystic ovary syndrome (PCO...
none12siThe diagnosis of polycystic ovary syndrome (PCOS) remains challenging due to limited data re...